Acute Lymphoblastic Leukemia
Methotrexate treatment is associated with good long-term neurocognitive outcomes
Published in Drug Week, October 27th, 2006
"CRT is associated with neurocognitive morbidity in survivors of childhood ALL. For most patients, CRT has been replaced with intensified systemic and intrathecal chemotherapy, often including methotrexate (MTX). The impact of chemotherapy-only protocols on neurocognitive outcomes is unclear, and the importance of systemic MTX dose has not been established," investigators in Canada report.
"Seventy nine of 120 eligible children diagnosed with high-risk ALL between the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2006-10-27)
More Articles from Drug Week
- Antituberculosis Drug Development
Front-line antitubercular drugs synergistic with ethylene diamine SQ109 - Cancer Therapy
PharmaGap cancer drug effective using systemic (intra-peritoneal) administration - Hereditary Angioedema
Jerini sees positive results from phase III trials of Icatibant for hereditary angioedema - Human Papillomavirus Vaccine
Human papillomavirus vaccine with AS04 adjuvant triggers persistent immune response - Acute Lymphoblastic Leukemia
Liposomal daunorubicin and cytarabine are effective as reinduction chemotherapy - Acute Myelogenous Leukemia
Juvaris wins innovation research grant for acute myelogenous leukemia vaccine development - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
